期刊文献+

高血压与非酒精性脂肪性肝病的关系 被引量:5

Association between hypertension and nonalcoholic fatty liver disease
下载PDF
导出
摘要 非酒精性脂肪性肝病(NAFLD)与高血压同为代谢综合征的重要组成部分,二者之间有很强的关联性。通过临床数据分析了NAFLD与高血压之间的联系。简述了二者之间相互影响的共同可能机制。其中,胰岛素抵抗、肠道菌群、肾素-血管紧张素-醛固酮系统在二者的发病机制中起着重要的作用。同时也总结了肾素-血管紧张素-醛固酮系统抑制药以及利尿剂在NAFLD治疗中的应用,为今后进一步明确二者之间的关系,深入了解二者相互影响的机制以及NAFLD合并高血压的治疗提供参考。 Nonalcoholic fatty liver disease(NAFLD)and hypertension are both important components of metabolic syndrome,and there is a strong association between these two diseases.This article analyzes the association between NAFLD and hypertension based on clinical data and describes the common pathogeneses of the two diseases,among which insulin resistance,gut microbiota,renin-angiotensin-aldosterone system play an important role in the pathogenesis of these two diseases.In addition,this article briefly summarizes the application of renin-angiotensin-aldosterone system inhibitors and diuretics in the treatment of NAFLD,which provides a reference for further clarifying the association between these two diseases,understanding the mechanism of interaction between the two diseases,and exploring the treatment methods for NAFLD with hypertension.
作者 王欣 胡义扬 刘平 冯琴 WANG Xin;HU Yiyang;LIU Ping;FENG Qin(Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine,Shanghai 201203,China;Shanghai Key Laboratory of Traditional Chinese Clinical Medicine,Shanghai 201203,China;Key Laboratory of Liver and Kidney Diseases,Ministry of Education,Shanghai 201203,China)
出处 《临床肝胆病杂志》 CAS 北大核心 2020年第11期2584-2588,共5页 Journal of Clinical Hepatology
基金 国家自然基金重点项目(81830119) 国家科技重大专项“重大新药创制”项目(2019ZX09201001-001-002)。
关键词 非酒精性脂肪性肝病 高血压 治疗学 non-alcoholic fatty liver disease hypertension therapeutics
  • 相关文献

参考文献5

二级参考文献133

  • 1Silvia Sookoian,María Alejandra Fernández,Gustavo Casta(n|~)o.Effects of six months losartan administration on liver fibrosis in chronic hepatitis C patients: A pilot study[J].World Journal of Gastroenterology,2005,11(48):7560-7563. 被引量:7
  • 2Paizis G,Cooper ME,Schembri JM,et al.Up-regulation of components of the renin-angiotensin system in the bile duct-ligated rat liver. Gastroenterology . 2002
  • 3X. Rong,Y. Li,K. Ebihara,M. Zhao,J. Naowaboot,T. Kusakabe,K. Kuwahara,M. Murray,K. Nakao.Angiotensin II type 1 receptor-independent beneficial effects of telmisartan on dietary-induced obesity, insulin resistance and fatty liver in mice[J]. Diabetologia . 2010 (8)
  • 4Paul M,Poyan Mehr A,Kreutz R.Physiology of local renin-angiotensin systems. Physiological Reviews . 2006
  • 5Al-Mallah M,Khawaja O,Sinno M,et al.Do angiotensinconverting enzyme inhibitors or angiotensin receptorblockers prevent diabetes mellitus?A meta-analysis. Cardiol J . 2010
  • 6Lubel JS,Herath CB,Burrell LM,Angus PW.Liver disease and the renin-angiotensin system: recent discoveries and clinical implications. Journal of Gastroenterology . 2008
  • 7E.F. Georgescu,M. Georgescu.Therapeutic options in non-alcoholic steatohepatitis (NASH). Are all agents alike? Results of a preliminary study. J Gastrointestin Liver Dis . 2007
  • 8Terui Y,Saito T,Watanabe H,Togashi H,Kawata S,Kamada Y,Sakuta S.Effect of angiotensin receptor antagonist on liver fibrosis in early stages of chronic hepatitis C. Hepatology . 2002
  • 9P.S. Leung.The physiology of a local reninangiotensin system in the pancreas. Journal of Physiology The . 2007
  • 10Yokohama S,Yoneda M,Haneda M,et al.Therapeutic efficacy of an angiotensin II receptor antagonist in patients with nonalcoholic steatohepatitis. Hepatology . 2004

共引文献107

同被引文献56

引证文献5

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部